Preferred Label : calcipotriene;

MeSH note : a topical dermatologic for the treatment of moderate plaque psoriasis; structure in first source;

CISMeF synonym : MC 903; dovonex; psorcutan; sorilux; Bristol-Myers squibb brand of calcipotriene; CSL brand of calcipotriene; farmacusi brand of calcipotriene; leo brand of calcipotriene; schering brand of calcipotriene; senosiain brand of calcipotriene;

MeSH synonym : 1,24(OH)2-22-ene-24-cyclopropyl D3; calcipotriol; MC903;

MeSH hyponym : Daivonex; MC-903;

MeSH CAS label : 9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-, (1alpha,3beta,5Z,7E,22E)-;

MeSH Related Number : 112965-21-6;

Registry Number MeSH : 112965-21-6;

Is substance : O;

UNII : 143NQ3779B;

InChIKey : LWQQLNNNIPYSNX-UROSTWAQSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3488641/fr/closalis-calcipotriol/betamethasone-psoriasis
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
adult
calcipotriol, combinations
administration, cutaneous
ointments
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug)
evaluation of the transparency committee
psoriasis

---
https://www.has-sante.fr/jcms/p_3389403/fr/wynzora-calcipotriol/betamethasone-psoriasis
2022
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
ointments
administration, cutaneous
calcipotriene
betamethasone dipropionate, calcipotriol drug combination
betamethasone
betamethasone-17,21-dipropionate
anti-inflammatory agents
calcipotriol, combinations
dermatologic agents
scalp dermatoses
Psoriasis of scalp (disorder)
Product containing only betamethasone and calcipotriol in cutaneous dose form (medicinal product form)
adult
evaluation of the transparency committee
psoriasis

---
https://www.has-sante.fr/jcms/p_3262271/fr/enstilar-calcipotriol-betamethasone
2021
false
false
false
France
betamethasone-17,21-dipropionate
treatment outcome
insurance, health, reimbursement
administration, cutaneous
calcipotriol, combinations
anti-inflammatory agents
glucocorticoids
adult
psoriasis
evaluation of the transparency committee
calcipotriene
betamethasone
calcitriol

---
http://www.has-sante.fr/portail/jcms/c_2752839/fr/daivonex
2017
false
false
false
France
French
evaluation of the transparency committee
administration, cutaneous
insurance, health, reimbursement
treatment outcome
calcipotriol
calcipotriene
calcitriol
calcitriol

---
https://www.has-sante.fr/portail/jcms/c_2803498/fr/enstilar
2017
false
false
false
false
France
French
evaluation of the transparency committee
calcipotriol, combinations
treatment outcome
insurance, health, reimbursement
administration, cutaneous
drug combinations
psoriasis
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
guidelines for drug use
dermatologic agents
anti-inflammatory agents
glucocorticoids
Topical Foam Dosage Form
adult
betamethasone
calcitriol
calcitriol
calcitriol
betamethasone
betamethasone

---
http://www.has-sante.fr/portail/jcms/c_2040751/fr/daivobet
2015
true
France
French
betamethasone dipropionate, calcipotriol drug combination
administration, topical
drug combinations
psoriasis
calcipotriol, combinations
calcipotriene
betamethasone
calcitriol
betamethasone-17,21-dipropionate
insurance, health, reimbursement
scalp dermatoses
administration, cutaneous
adult
treatment outcome
gels
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1743051/fr/xamiol
http://www.has-sante.fr/portail/jcms/c_778871/xamiol
2014
false
false
false
France
French
evaluation of the transparency committee
calcipotriol, combinations
administration, topical
insurance, health, reimbursement
treatment outcome
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
psoriasis
scalp dermatoses
adult
meta-analysis as topic
glucocorticoids
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
betamethasone
betamethasone
calcitriol
calcitriol
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1743048/fr/daivobet
http://www.has-sante.fr/portail/jcms/c_968478/daivobet
2014
false
France
French
betamethasone dipropionate, calcipotriol drug combination
administration, topical
drug combinations
psoriasis
calcipotriol, combinations
calcipotriene
betamethasone
calcitriol
betamethasone-17,21-dipropionate
insurance, health, reimbursement
scalp dermatoses
administration, cutaneous
adult
treatment outcome
gels
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1356879/daivonex
http://www.has-sante.fr/portail/upload/docs/evamed/CT-11978_DAIVONEX_rad_PIC_avis2_CT11978.pdf
2013
France
French
corticosteroid therapy
evaluation of the transparency committee
administration, cutaneous
calcipotriol
administration, topical
psoriasis
drug recalls
dermatologic agents
dermatologic agents
calcitriol
calcipotriene
calcipotriene

---
http://www.has-sante.fr/portail/jcms/c_819524/xamiol-calcipotriol-et-betamethasone-en-application-locale
http://www.has-sante.fr/portail/jcms/c_779196/xamiol-ct-6219
2009
France
French
betamethasone dipropionate, calcipotriol drug combination
calcitriol
drug combinations
betamethasone
psoriasis
scalp dermatoses
calcipotriene
betamethasone-17,21-dipropionate
calcipotriol, combinations
evaluation of the transparency committee
guidelines for drug use

---
https://rmlg.uliege.be/article/1380
2006
Belgium
French
psoriasis
betamethasone dipropionate, calcipotriol drug combination
drug combinations
betamethasone
calcitriol
Evidence-Based medicine
administration, cutaneous
treatment outcome
randomized controlled trials as topic
betamethasone dipropionate, calcipotriol drug combination
drug administration schedule
calcipotriene
calcipotriol, combinations
drug information
journal article

---
https://rmlg.uliege.be/article/1340
2005
Belgium
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
psoriasis
administration, topical
glucocorticoids
anti-inflammatory agents
betamethasone
calcitriol
dermatologic agents
drug combinations
calcipotriol, combinations
journal article
drug information

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.